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The HIV-1 has evolved swiftly and the scenario of HIV-1 genetic diversity is constantly changing. In
South America, recombinant forms of subtypes B, F1, and BF1 have historically driven the HIV-1
epidemic. In recent years, however, infection with subtype C has gained prominence as its prevalence
increased in Southern Brazil as well as neighboring countries. Current studies point to a single
introduction of closely related strains as the beginning of the Brazilian subtype C epidemic. However,
the place of origin of these strains, date, and route of introduction are under continuous debate as well
as the clinical outcomes of the emergence of subtype C. Therefore, this paper reviews the history of the
HIV-1 subtype C in Brazil, particularly in the Southern region, covering its demographic and
evolutionary history and the possible implications to the Brazilian AIDS epidemic as well as to
neighboring countries.
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The ﬁrst AIDS case was diagnosed in Brazil in 1982 and since
then 608,230 cases had been reported throughout the country
(Brazilian Ministry of Health, 2011). The prevalence of AIDS in the
adult population is 0.6% and the incidence of new cases was 17.9/
100,000 inhabitants in 2010. With a population exceeding 192ll rights reserved.
to).million, Brazil has the largest number of HIV infected people
among countries from Central and South America, and according
to UNAIDS accounts for one third of all people living with HIV in
this region (Brazilian Institute of Geography and Statistics [IBGE],
2012; World Health Organization [WHO], 2010).
Brazil is a country of continental dimensions, spread over an area
of 8,514,877 km2 which occupies roughly half of South America,
divided into 26 states and a Federal District, which are grouped into
ﬁve geopolitical regions. The states of Rio Grande do Sul (RS), Santa
Catarina (SC), and Parana´ (PR) compose the Southern region, which is
the smallest region of the country with a population of 27 million,
Fig. 1. Prevalence of HIV-1 subtype C and C-containing sequences in Brazilian
states and South American countries. Acronyms for Brazilian states: RS (Rio
Grande do Sul), SC (Santa Catarina), PR (Parana´), SP (S~ao Paulo), RJ (Rio de Janeiro),
MG (Minas Gerais), ES (Espı´rito Santo), BA (Bahia), SE (Sergipe), AL (Alagoas), PE
(Pernambuco), PB (Paraı´ba), RN (Rio Grande do Norte), CE (Ceara´), PI (Piauı´), MA
(Maranh~ao), PA (Para´), AP (Amapa´), AM (Amazonas), RR (Roraima), AC (Acre), RO
(Rondoˆnia), MT (Mato Grosso), TO (Tocantins), GO (Goia´s), MS (Mato Grosso do
Sul), and DF (Distrito Federal).
T. Gra¨f, A.R. Pinto / Virology 435 (2013) 170–178 17114% of its total population (Brazilian Institute of Geography and
Statistics [IBGE], 2012). This region shares borders with Uruguay,
Argentina, and Paraguay, as well as with the Brazilian states of S~ao
Paulo and Mato Grosso do Sul (Fig. 1).
The epidemiological situation in Southern Brazil regarding AIDS
is concerning. The AIDS-related mortality is steadily increasing and
ever since the beginning of the 2000s is highest among Brazilian
regions (Brazilian Ministry of Health, 2011). The number of newly
diagnosed cases is also the highest in the country, and in 2010 the
incidence rates in the states of Rio Grande do Sul and Santa Catarina
were 37.6 and 30.2 new cases per 100,000 persons, respectively,
whereas in the state of Parana´ the incidence rate was 19 new cases
per 100,000 persons. Moreover, the top ten Brazilian cities with the
highest incidence of AIDS in 2010 were from the Southern region,
and Porto Alegre, the capital city of Rio Grande do Sul, had an
incidence of 99,8 new cases per 100,000 persons, the highest
incidence of AIDS in the country (Brazilian Ministry of Health, 2011).
High molecular variability is a striking feature of HIV-1 in the
global AIDS pandemic. Among four HIV-1 groups (M, N, O, and P),
HIV-1 group M is globally distributed, being subdivided into nine
subtypes (A–D, F–H, J, and K) and, 51 circulating recombinantforms (CRFs) identiﬁed so far (Ng et al., 2012; Plantier et al., 2009;
Tebit and Arts, 2011). The AIDS pandemic in Brazil is mostly
caused by the HIV-1 subtype B, while subtypes C, F1, and BF1
recombinants are observed in lower frequencies (Gadelha et al.,
2003; Machado et al., 2009; Pedroso et al., 2007; Sa Filho et al.,
2005; Stefani et al., 2007; Teixeira et al., 2004). However, the
distribution of HIV-1 variants is heterogeneous in the inner parts
of the country, while subtype C is highly prevalent in Southern
Brazil (Gra¨f et al., 2011; Medeiros et al., 2011; Silva et al., 2010).
Currently, subtype C and C-containing forms are responsible for
more than 51% of all worldwide HIV-1 infections (Tebit and Arts,
2011). Dominant in India, Southern African countries, and with
increasing presence in China and Eastern Africa, subtype C and C-
containing recombinant forms appear to spread more rapidly than
other group M subtypes (Arie¨n et al., 2007; Tebit and Arts, 2011).
Moreover, increasing subtype C prevalence has been reported in
some countries from Western Europe, the Americas, and Australia
(Abecasis et al., 2011; Chibo and Birch, 2012; Dougan et al., 2005;
Tatt et al., 2004; Tebit and Arts, 2011). Due to the high prevalence of
HIV-1 subtype B in developed countries, research on the natural
history and health technology improvements have largely focused
on this variant. However, the actual global epidemiological proﬁle
requires further studies evaluating the impact of HIV-1 diversity,
especially the dominant subtype C on disease progression and
treatment outcomes. Thus, molecular epidemiology studies are
pivotal for evaluating phenotypic relevance and providing under-
lying data concerning viral diversity and evolution.
In Brazil, studies published over a decade have investigated
the molecular features of the local HIV epidemic, producing
valuable data regarding the importance of subtype C and
C-containing recombinant forms in the Southern region and its
implications to neighboring countries as well other Brazilian
states. Given the extensive bibliography available and the actual
global relevance of HIV-1 subtype C, this article aims to review
the history of subtype C in Brazil, from the early cases in the
South to the increasing prevalence in the North.Origin of Brazilian HIV-1 C clade
The history of how HIV-1 subtype C was introduced in Brazil is
being revealed as new epidemiological data are published and
more Brazilian subtype C sequences become available. The ﬁrst
phylogenetic analyses indicated that subtype C may have entered
Brazil with a single introduction of closely related strains, since
Brazilian subtype C sequences (CBR) formed a monophyletic
cluster when compared to sequences of the same subtype from
India and some African countries (Monteiro et al., 2007; Sanabani
et al., 2006; M.A. Soares et al., 2003). Furthermore, amino acid
signatures absent in the subtype C world consensus sequence
were identiﬁed in CBR, reinforcing a monophyletic introduction
hypothesis (M.A. Soares et al., 2003). Early studies also reported a
smaller genetic distance between sequences of CBR compared
with Brazilian subtype B sequences, suggesting a more recent
introduction of HIV-1 C than subtype B in Brazil (Monteiro et al.,
2007; Sanabani et al., 2006; Soares et al., 2005).
The strong evidence supporting a monophyletic origin of the
Brazilian HIV-1C epidemic prompted questions regarding the
geographical origin and migration route of the founder strains.
In 2008, two studies began elucidating this issue, reporting that
CBR sequences were closely related to subtype C sequences from
Middle East African countries (Bello et al., 2008; Fontella et al.,
2008). More speciﬁcally, sequences from Burundi at the root of
the Burundi–Brazilian clade showed that CBR originated from a
strain related to this country (Bello et al., 2008). Due to scarce
social, cultural, and economic relationships between Brazil and
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ing countries (Democratic Republic of Congo, Rwanda, or Tanzania)
into Brazil was further evaluated (Brı´gido, 2009). Regarding cul-
tural, social, and historical determinants, Mozambique was a
putative source for the Brazilian HIV-1C epidemic; however, phy-
logeny estimations lacked evidence for a Mozambican ancestry
(Brı´gido, 2009; Fontella et al., 2009). A new hypothesis for the
introduction of HIV-1C in Brazil emerged recently. Phylogenic
analysis revealed that subtype C sequences from the United King-
dom (UK), Brazil, and East Africa grouped together in a mono-
phyletic cluster, where some UK sequences appeared at the base of
the Brazilian HIV-1C clade (Oliveira et al., 2010). This suggests that
the UK may have played a key role in the introduction of HIV-1C
into Brazil. A more recent phylogeographic analysis, however, found
no evidence of a direct viral ﬂow from the UK to Brazil, only from
both East Africa and Brazil to the UK (Ve´ras et al., 2011), which may
be expected since the UK is home to large Brazilian and East African
immigrant populations. Thus, the precise migration route of HIV-1C
from East Africa to Brazil remains unclear.
The exact time when the HIV-1 CBR clade was introduced in Brazil
is also controversial. The onset date of subtype C epidemic in Brazil
was ﬁrst estimated by Salemi et al. (2005), which reported the early
1990s as the most likely period for HIV-1C introduction, about 30
years after subtype B was introduced. Some years later, Bello et al.,
2008 reestimated the onset year for the HIV-1 subtype C epidemic in
Brazil, citing the early 1980s as the probable time of introduction.
Subtype C sequences from patients infected in the 1980s were
included in this study, supporting the hypothesis of an introduction
prior to 1990. More recently, Ve´ras et al. (2011) reevaluated the
dates, suggesting an introduction between the 1960s and the 1970s.
The latter study included sequences from the three states that
compose Southern Brazil plus the state of S~ao Paulo, while Bello
et al. only included sequences from the state of Rio Grande do Sul,
which may explain differences between the two estimates.Recognition of the HIV-1 C epidemic in Rio Grande do Sul
Despite the idea that CBR clade probably circulated in Brazil
before the early 1980s, the existence of an established subtype CTable 1
Summary of studies in HIV molecular epidemiology performed in the state of Rio Gran
Reference City Sampling n
(ARV exposure)
Sampling year
Martı´nez et al. (2002) Rio Grande 69 (naı¨ve and
treated)
1994–1997
M.A. Soares et al. (2003) Porto Alegre 57 (naı¨ve) 2001
Brindeiro et al. (2003) Not available 139 (naı¨ve) 2001
E.A. Soares et al. (2003) Porto Alegre 77 (naı¨ve and
treated)
2002
E.A. Soares et al. (2005) Rio Grande 85 (naı¨ve and
treated)
2002
Rodrigues et al. (2006) Porto Alegre 108 (naı¨ve) 2004




Monteiro et al. (2007) Porto Alegre 22 (unknown) 2003
Brı´gido et al. (2007) Porto Alegre 122 (naı¨ve) 2004–2006
Dias et al. (2009) Porto Alegre 128 (naı¨ve) 2004–2005
Simon et al. (2010) Canoas 80 (naı¨ve and
treated)
2008–2009
Medeiros et al. (2011) Porto Alegre 99 (naı¨ve) 2006–2007
Silveira et al. (2012) Rio Grande 245 (naı¨ve) 2005–2008
PR/RT to protease/reverse transcriptase, CN to connection, RH to RNase H.
a Values reported by Santos et al. (2007).epidemic in the country was only recognized in the 1990s. The
WHO Network for HIV Isolation and Characterization (1994)
reported for the ﬁrst time the existence of HIV-1C in Latin
America. This subtype was found in 14 clinical samples obtained
in Porto Alegre (capital city of Rio Grande do Sul) between 1992
and 1993. Shortly after that, the same group identiﬁed subtype C
in three other Brazilian patients, two from Porto Alegre and one
from S~ao Paulo (capital city of S~ao Paulo) (Osmanov et al., 1994).
At the time only subtypes B and F1 had been identiﬁed in South
America, and the possibility of a subtype C epidemic in Southern
Brazil motivated several other studies focusing on the molecular
epidemiology of HIV-1.
The real scenario of the HIV epidemic in Southern Brazil began
to be unraveled in 2002 when Martı´nez et al. found 22% of subtype
C among samples collected between 1994 and 1997 in Rio Grande,
a port city in the state of Rio Grande do Sul. In 2003 Soares M.A.
et al. corroborated these ﬁndings reporting a 37% prevalence of
HIV-1C in the state of Rio Grande do Sul, reaching as high as 44%
when recombinant viruses containing subtype-C related sequences
were considered. Also in 2003, the Brazilian Network for HIV Drug
Resistance Surveillance reported a high frequency of BC recombi-
nant strains in samples from Rio Grande do Sul, showing the
intermixing of subtype B and C epidemics in Southern Brazil
(Brindeiro et al., 2003). Table 1 summarizes all studies performed
in the state of Rio Grande do Sul before the publication of this
review. The co-circulation of multiple HIV-1 clades in a restricted
geographic region favors the emergence of recombinant forms, as
observed frequently in some sub-Saharan countries (Tebit and Arts,
2011). In Southern Brazil, the epidemiological scenario also proved
favorable to the emergence of HIV recombinant forms.
Identiﬁcation of a new CRF_BC in Rio Grande do Sul
The high variability of HIV is also a consequence of recombi-
nation events. Inter-subtype recombination occurs when an
individual is co-infected with two different HIV strains at once,
or when a previously infected individual acquires a different
strain of HIV, which is called superinfection. These two phenom-
ena lead to the emergence of unique recombinant forms (URFs) or
circulating recombinant forms (CRFs). In Brazil recombinationde do Sul (RS), Southern Brazil.
HIV-1 diversity Gene analyzed
22% C, 75% B, 3% F env
37% C, 7% CB, 56% BþF1 pol (PR/RT)
45% C, 30% B, 3% F1, 22% recombinants pol (PR/RT)
31% C, 45% B, 12% F1, 9% CRF31a, 1,5% BF1, 1,5% BD pol (PR/RT)
41% C, 42% B, 5% F1, 4% CRF31a, 2% D, 6% URF pol (PR/RT)
33% C, 32% B, 3% F1, 25% CRF31a, 7% others pol (PR/RT)
31% C, 46% B, 4% F1, 10% CRF31, 9% others pol (PR/RT)
27% C, 37% B, 4.5% F1, 27% BC, 4.5% BF1 env and gag
27% C, 30% B, 10% F1, 21% CRF31, 8% URF_BC, 4% URF env and pol (PR/RT)
32% C, 25% B, 11% F1, 26% CRF31, 6% URF pol (PR/RT)
44% C, 19% B, 2% F1, 35% CRF31 pol (PR/RT)
40% C, 26% B, 1% F1, 19% CRF31, 12% URF_BC, 2%
URF_BF1
pol (PR/RT)
56% C, 21% B, 5% F1, 10.5% URF_BC, 0.5% CRF31, 6%
URF_BF1, 1% others
pol (PR/RT, CN and RH)
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mosaic as the most prevalent HIV genetic form after subtype B in
most of the country (Guimar~aes et al., 2008; Sa Filho et al., 2006).
The introduction of subtype C in the Southern region, however,
gave rise to several BC mosaic strains and a new CRF.
Most of the early studies revealing the high prevalence of
subtype C in the state of Rio Grande do Sul also reported frequencies
of recombinant BC forms ranging between 6% and 22% (Brindeiro
et al., 2003; M.A. Soares et al., 2003, 2005). Rodrigues et al. reported
in 2006 a remarkable 25% of BC recombinants in samples from
Porto Alegre. Detailed analyses of these BC sequences showed high
similar recombinant structure, lower intra-cluster distances, and
common amino acid signatures, pointing strongly to a new circulat-
ing recombinant variant. Shortly afterward, Santos et al. (2006)
characterized this relevant BC recombination form as a new CRF
named CRF31_BC. This HIV-1 variant features a predominantly
subtype C genome, with a 240bp subtype B fragment inserted in
the reverse transcriptase gene.
Previous studies indicate that the CRF31_BC clade likely
originated in the late 1980s and rapidly expanded in the city of
Porto Alegre (Passaes et al., 2009). The prevalence of the
CRF31_BC in this city was estimated to be 10% in samples
collected between 2002 and 2003 and 25% in samples from
2004 (Santos et al., 2007) (Table 1). Despite occasional detection
of CRF31_BC clade beyond Porto Alegre, the prevalence of this
recombinant variant in other cities in Rio Grande do Sul, Santa
Catarina, and Parana´ seems to be much lower (o5%) (Brı´gido
et al., 2007; Gra¨f et al., 2011; Raboni et al., 2010; Rodrigues et al.,
2010; Silva et al., 2010; Silveira et al., 2012).The HIV-1 C epidemic in Santa Catarina and Parana´
The unique features of the HIV/AIDS epidemic in the state of Rio
Grande do Sul galvanized researchers to better understand HIV-1
molecular epidemiology in the Southern Brazilian region. In 2007,
the ﬁrst cases of subtype C infection were reported in Santa
Catarina, a southern state without previous HIV-1 molecular data,
in a small group of three female sex workers from the city of
Imbituba (Schuelter-Trevisol et al., 2007). Shortly after that,
Locateli et al. (2007) reported a 48% frequency of subtype C in
samples obtained in 2004 from Floriano´polis (capital city of Santa
Catarina). Frequencies of subtype C over 60% were reported a few
years later in Florianopo´lis, Camboriu´, Itajaı´, and Criciu´ma (Brı´gido
et al., 2007; Gra¨f et al., 2011; Rodrigues et al., 2010; Pinto et al.,
2012), making Santa Catarina the state with the highest prevalence
of HIV-1C in Brazil. High prevalence (16%) of URF_BC in SantaTable 2
Summary of studies in HIV molecular epidemiology performed in the states of Santa C






Imbituba/SC 4 (naı¨ve) 2003
Locateli et al. (2007) Floriano´polis/SC 80 (naı¨ve and treated) 2004
Brı´gido et al. (2007) Itajaı´ and Camboriu´/ SC 83(naı¨ve) 2004
Rodrigues et al. (2010) Criciu´ma/SC 42 (naı¨ve and treated) 2007
Gra¨f et al. (2011) Floriano´polis/SC 82 (naı¨ve) 2008
Brindeiro et al. (2003) Not available/PR 147 (naı¨ve) 2001
Ferreira et al. (2008) Curitiba/PR 38 (naı¨ve) 2005
Toledo et al. (2010) several cities/PR 389 (virological failure) 2003
Raboni et al. (2010) several cities/PR 239 (virological failure) 1999
Silva et al. (2010) Curitiba/PR 191 (virological failure) 1987
PR/RT to protease/reverse transcriptase, CN to connection, RH to RNase H.Catarina was also reported, reﬂecting the co-existence of subtypes
C and B in the same population (Gra¨f et al., 2011).
The ﬁrst molecular epidemiology study in the state of Parana´,
conducted by Brindeiro et al. in 2003, reported a subtype C
prevalence of 30%, the same frequency subsequently reported
by Ferreira et al., 2008 in the capital city (Curitiba). More recently,
Toledo et al. (2010), Raboni et al. (2010) and Silva et al. (2010)
evaluated patient samples from several cities in Parana´, reporting
21–27% of subtype C in patients with therapeutic failure. Raboni
et al. (2010) also observed higher proportion of subtype C (31%) in
cities located in the southern region of the state of Parana´,
bordering Santa Catarina, while in the northern region of the
state, which borders S~ao Paulo state, only 13% of subtype C was
observed. Table 2 summarizes the studies performed in the states
of Santa Catarina and Parana´.Temporal trends and spatial dynamics of HIV-1 C expansion
and CRF31_BC epidemics in Southern Brazil
Reconstruction of the demographic history of subtype C and
CRF31_BC epidemics in Porto Alegre, performed using a Bayesian
coalescent-based approach, indicates that both HIV-1 clades
experienced a period of fast exponential spread in this Brazilian
city during the 1980s and 1990s (Bello et al., 2009). Consistent
with this ﬁnding, E.A. Soares et al. (2003) observed an increasing
frequency of subtype C in the city of Porto Alegre from 0% among
patients diagnosed before 1990 to 43% in patients diagnosed
between 2001 and 2002. The following studies conﬁrmed the
continued increase in HIV-1 subtype C infections in Porto Alegre:
27% reported by Brı´gido et al. (2007), 32% observed by Dias et al.
(2009), and 40% reported by Medeiros et al. (2011). A study
conducted in the city of Canoas (Porto Alegre metropolitan area)
found 44% of subtype C in 2010 (Simon et al., 2010). In the same
reports, the frequency of subtype B sharply decreased since the
early 2000s.
In general, the proportion of CRF31_BC also increased over
time in Porto Alegre, though not linearly. A wide variation in the
frequency of CRF31_BC between published studies is observed
and may reﬂect the difﬁculties in identifying the recombination
pattern, featured by a short subtype B insertion within a whole
subtype C genome. In addition, minimal variations in the point of
recombination of CRF31_BC get in the way of the classiﬁcation,
which can reclassify the strain into a second generation recombi-
nant form or a URF_BC (Passaes et al., 2009). Therefore, the
differences between CRF31_BC and unique recombination forms
may be minimal, explaining why a lower prevalence of CRF31_BCatarina (SC) and Parana´ (PR), Southern Brazil.
pling HIV-1 diversity Gene analyzed
–2004 75% C, 25% B pol (PR/RT)
49% C, 22.5% B, 22.5% BC, 6% BF1 env and gag
–2006 64% C, 26.5% B, 6% F1, 3.5% CRF31 env and pol (PR/RT)
79% C, 7% B, 9.5% F1, 2% CRF31, 2.5% CF1 pol (PR/RT)
–2009 66% C, 13.5% B, 1% F1, 2.5% CRF31, 16%
URF_BC, 1% URF_BCF
env and pol (PR/RT/INT)
30% C, 64% B, 4% F1, 2% rec. pol (PR/RT)
–2006 30% C, 52% B, 2% F1, 14% BC, 2% CF1 env and pol (PR/RT)
–2006 21% C, 61% B, 5% F1, 2.5% BC, 10.5% BF1 pol (PR/RT)
–2007 26.5% C, 52% B, 10.5% F1, 8.5% URF pol (PR/RT)
–2008 21.5% C, 69% B, 5% F1, 4% URF_BF, 0.5%
URF_CF
pol (PR/RT)
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in some studies.
A temporal increase of subtype C was also observed in other
cities from Rio Grande do Sul and Santa Catarina, including Rio
Grande and Floriano´polis, respectively. A subtype C prevalence of
41% was reported in the city of Rio Grande in 2005 and 56% in
2012, over twice as high as the ﬁrst work performed in the same
city in 2002 (Martı´nez et al., 2002; Silveira et al., 2012; Soares
et al., 2005). Evaluation of the HIV-1 genotype distribution at the
env gene from two studies performed in Floriano´polis also
revealed a signiﬁcant increase in the proportion of subtype C in
the heterosexual population over time: from 56% in 2004 to 83%
in 2008–2009 (Gra¨f et al., 2011), while the proportion of subtype
B in that population decreased from 38% to just 15% in the same
period.
No similar temporal increase in the prevalence of subtype C
has been detected in Parana´. The prevalence of this HIV-1 subtype
has remained relatively stable (20–30%) across different studies
performed between 2003 and 2010 (Brindeiro et al., 2003;
Ferreira et al., 2008; Raboni et al., 2010; Silva et al., 2010;
Toledo et al., 2010). A signiﬁcant increase in the frequency of
URFs_BC over time, however, was reported in Parana´ by Ferreira
et al. (2008), probably reﬂecting the frequent and ongoing co-
infections of patients living in this region with HIV-1 subtypes C
and B clades.
Regarding the spatial dynamics of the HIV-1C epidemic in
Brazil, two recent reports using phylogeography inference point
to the state of Parana´ as the most likely source of subtype C in the
southern region (Bello et al., 2012a; Ve´ras et al., 2011). The study
of Ve´ras et al. (2011) indicates that subtype C expanded trough
Southern Brazil with an asymmetrical net viral ﬂow following a
north to south axis, from Parana´ to both Santa Catarina and Rio
Grande do Sul. A recent study performed by our group with a
large number of sequences collected from the three southern
capitals reveals a much more complex scenario (Bello et al.,
2012a). According to our analyses, Floriano´polis (capital of Santa
Catarina) acted as an important staging post between Curitiba
(capital of Parana´) and Porto Alegre (capital of Rio Grande do Sul),
both receiving and sending viral lineages to the neighboring
cities. Meanwhile, the direct viral migration ﬂow between Cur-
itiba and Porto Alegre seems to be much lower. Such estimated
subtype C migration ﬂows could be partially explained by the
spatial distance and routine migration of people between South-
ern Brazilian states.HIV-1C expansion throughout the country
In general, subtype C seems to be slowly expanding north in
the Brazilian territory as can be seen in Fig. 1. In 2010 a slight
increase in the prevalence of HIV-1C was observed in the state of
S~ao Paulo, ranging from 0.3% in samples from 2005 to 2.9% in
2008, reaching 8.3% if only newly diagnosed patients from 2008
are considered (Brı´gido et al., 2011). These ﬁndings were recentlyFig. 2. HIV-1 diversity in the Brazilian state capitals mainly affected by subtype C epide
Gra¨f et al. (2011), Silva et al. (2010), Ferreira et al. (2011), and Carvalho et al. (2011).conﬁrmed by a study reporting 7.3% of subtype C and
C-containing sequences in the city of S~ao Paulo (Alcalde et al.,
2012). No evidence of fast expansion of subtype C has been
reported in other Southeast states, including Rio de Janeiro and
Minas Gerais (Castro et al., 2010; Westin et al., 2011). Thus,
despite the close geographical proximity and the frequent routine
movement of people from the Southern region, subtype B con-
tinues to be the widely dominant HIV-1 clade in Southeast Brazil.
Nonetheless, a relatively high prevalence of HIV-1C infections
has been reported recently in some states from the Central-West,
North and Northeast regions. In 2009, a study from the Brazilian
Network for HIV Drug Resistance Surveillance found 6% of sub-
type C in the state of Para´ and in the national capital Brası´lia
(Inocencio et al., 2009). In 2011, two studies reported, respec-
tively, 11.7% and 9.6% of subtype C and C-containing forms in the
inland cities of Cuiaba´, capital of Mato Grosso (MT), and Palmas,
capital of Tocantins (TO) (Ferreira et al., 2011; Carvalho et al.,
2011) (Fig. 2). Also in 2011, a frequency of subtype C and
C-containing forms of close to 20% was reported by a study
performed in inmates from Central-West Brazil (Cardoso et al.,
2011). Due to job opportunities in agriculture and livestock,
Brazilian Central-West region attracts a large number of immi-
grants, mainly from the Southern region. Therefore, it is possible
that this migration route is responsible for the dissemination of
subtype C to this region in recent years. Moreover, a prevalence of
5.4% HIV-1C was recently reported in the state of Ceara´ (CE), the
highest prevalence ever recorded in that state (Arruda et al., 2011).HIV-1C in South American countries
The HIV epidemic in South American countries is characterized
by a predominant circulation of subtypes B and BF recombinants,
with the latter being observed with higher prevalence in Southern
Cone countries (Dilernia et al., 2007; Montano et al., 2005;
Ruchansky et al., 2009). Carrion et al., 2004 were the ﬁrst to
report HIV-1 subtype C infections in South America after analyz-
ing 1629 samples from Ecuador, Colombia, Bolivia, Venezuela,
Peru, Chile, Argentina, Paraguay, and Uruguay. Seven subtype C
and one BC strains were identiﬁed in Argentina, Paraguay, and
Uruguay, countries that share borders with the Brazilian Southern
region and compose the so-called Southern Cone. Corroborating
these ﬁndings, subsequent reports also observed prevalence of
less than 1% in subtype C or C-containing forms in patients from
Ecuador, Peru, and Southern Cone countries (Aulicino et al.,
2005a, 2005b; Montano et al., 2005; Pando et al., 2006). In these
reports, patients infected with HIV-1C or C-containing forms
frequently reported some epidemiologic link to Brazil, such as
living in border towns or having had sexual partners from Brazil.
Lately several studies have detected the circulation of subtype C in
Paraguay, Uruguay, and Argentina, although still at low frequencies,
accounting for less than 5% of the HIV infections in those countries
(Aguayo et al., 2008; Pando et al., 2011; Ruchansky et al., 2009). In
addition, Jones et al. described in 2009 two CRF31_BC sequences inmic according to the most recent studies. Data according to Medeiros et al. (2011),
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HIV-1C and related BC sequences from Brazil to neighboring countries
from the Southern Cone. In fact, HIV-1C sequences from Argentina
and Uruguay were found to be closely related to Brazilian strains in
several phylogenetic studies, supporting the hypothesis of a single
introduction of subtype C in Southern Brazil which later spread to
other South American countries (Dilernia et al., 2007; Fontella et al.,
2008; Jones et al., 2009; Monteiro et al., 2007; Ve´ras et al., 2011).
Nevertheless, studies performed in Venezuela in 2005 and 2012
found subtype C sequences that grouped outside the Brazilian HIV-
1C cluster (Castro et al., 2005; Rangel et al., 2012). Epidemiologic data
showed that two of these sequences were originated from patients
most likely infected in South Africa, while the other case was
identiﬁed in an Amerindian woman who lacked epidemiological
information. Though these studies raised the possibility that new
HIV-1C lineages may have been introduced in South America, more
speciﬁcally in Venezuela, a more comprehensive study performed in
2009 did not detect subtype C infections in 425 Venezuelan patients
(Rangel et al., 2009). The HIV-1 epidemic in Venezuela is predomi-
nantly driven by subtype B and the few reported cases of HIV-1C
infections might not mean that subtype C is circulating in the
Venezuelan population. In Fig. 1 the overall prevalence of HIV-1C
and C-containing sequences in South American countries is shown.The subtype C epidemic and its relevance
The rapid emergence of HIV-1 subtype C globally warrants
special attention to the pathogen itself. However, little is known
about genotypic and phenotypic differences that could explain
how or why HIV-1 subtype C is associated with the disastrous
epidemic in Southern Africa and its rapid emergence in other
countries. Salemi et al. (2005) investigated differences in epi-
demic behavior between subtypes B and C in Brazil. Using a
Maximum Likelihood coalescent-based approach, Salemi et al.
estimated that the CBR epidemic expanded twice as fast as
Brazilian subtype B or even South African subtype C. Subsequent
studies using Bayesian coalescent-based methods also indicate
that the mean growth rate of the CBR epidemic (0.70–0.87 year
1)
was higher than that estimated for the BBR (0.46–0.56 year
1) and
F1BR (0.59–0.69 year
1) epidemics (Bello et al., 2008, 2009,
2012b). Despite such differences, the conﬁdence intervals of those
estimates displayed a great overlap making it unclear whether the
initial rate of dissemination of different Brazilian HIV-1 subtypes
was or in fact signiﬁcantly different (Bello et al., 2011).
As reviewed by Arie¨n et al. (2007), the successful worldwide
dissemination of subtype C may be due to this strain being less
virulent in comparison with other HIV-1 group M subtypes while
maintaining the same transmission efﬁciency. Subtype C strains
predominantly use CCR5 co-receptor and rarely switch to CXCR4
or dual tropic use (Vasan et al., 2006). A switch to CXCR4 usage
has been associated with acceleration of disease progression.
Furthermore, Abraha et al. (2009) showed in ex vivo experiments
that subtype C HIV-1 isolates might have a reduced replicative
ﬁtness in peripheral blood mononuclear cells. This HIV-1C feature
may reﬂect in a decrease in CD4 cell count, which supports the
ﬁndings reported by Silveira et al. (2012) with higher CD4 cell
counts in subtype C infected patients compared with patients
infected with other HIV-1 subtypes. A lower pathogenicity of HIV-
1C would lead to a long asymptomatic period, which would
increase opportunity for transmission and favor the epidemic
expansion. Although the lower pathogenicity of HIV-1C may have
contributed to a rapid dissemination of this subtype in Southern
Brazil, the relatively slow rate of expansion of subtype C in other
Brazilian regions and South American countries that share bor-
ders with Southern Brazil suggests that factors other thanintrinsic viral transmissibility have also shaped the dissemination
pattern of HIV subtypes in the Southern Cone.
Among these factors, the viral transmission networks and the
availability of host individuals may have had a central role in the
forging of the current epidemiological scenario. Several epide-
miological studies in Southern Brazil observed a relevant associa-
tion between HIV-1C and heterosexual individuals of both
genders, while HIV-1B was found to be more frequent in men
who have sex with men (MSM) (Brindeiro et al., 2003; Gra¨f et al.,
2011; Raboni et al., 2010; Silva et al., 2010; Silveira et al., 2012;
Soares et al., 2005; Toledo et al., 2010). The number of HIV
infected people in the heterosexual exposure category has been
increasing rapidly in Brazil due to a process of feminization of the
AIDS epidemic: in 1990 the man/woman new AIDS cases ratio
was 5.4 while in 2009 it had decreased to 1.6 (Brazilian Ministry
of Health, 2011). It is conceivable that an efﬁcient introduction of
subtype C in the heterosexual group allowed for a rapid spread
through a large and expanding network of host individuals.
Therefore, segregation of exposure categories and HIV-1 variants
may be due to differences in the transmission networks where
subtypes were introduced and disseminated at early times, rather
than to differences in viral transmissibility. A study assessing the
temporal dynamics of HIV-1 subtypes in different exposure
categories in Porto Alegre observed a signiﬁcant increase in
subtype C in both heterosexual and MSM individuals over time,
resulting in a progressive loss of the association between HIV
subtypes and exposure categories (Almeida et al., 2011).
A progressive intermixing of the epidemics and the consequent
loss of associations between HIV variants and exposure categories
appears to be a natural tendency as seen in other countries
(Tovanabutra et al., 2004). On the other hand, a study performed
in Porto Alegre by Dias et al. (2009) found evidence of a different
viral transmission pattern. This study, although based on a small
sample size, linked anal sex to clade B transmission in both
genders – and not only in the MSM exposure category. These
ﬁndings suggest that though transmission networks might justify
most clade segregation, clade C could be less dependent on high-
risk anal sex behavior, a factor that could favor its heterosexual
transmission. However, very little is known about differences in
pathogenic potential and transmissibility of HIV-1 subtypes, and
further studies are needed to explain this issue.
Another important issue that needs to be addressed is whether
HIV-1 subtypes may differ in susceptibility to antiretroviral (ARV)
treatment and the rate of ﬁxation of mutations conferring drug
resistance. Again, little data is available on the impact of anti-
retroviral therapy on subtype C and other non-subtype B strains,
since HIV-1B are dominant in developed countries and most ARVs
were designed for subtype B. Nevertheless, some studies have
reported that under drug selective pressure subtype C may
acquire drug resistance faster than other strains. K65R muta-
tion confers partial resistance to most nucleoside reverse tran-
scriptase inhibitors (NRTIs) and is selected by NRTIs such as
tenofovir (TDF), abacavir (ABC), and didanosine (ddI) (Brenner
and Coutsinos, 2009). The overall incidence of K65R is very low
due to high genetic barriers and ﬁtness constraints, but K65R was
observed in 23–30% of subtype C patients failing therapy in Africa
who were genotyped (Doualla-Bell et al., 2006; Hosseinipour
et al., 2009). In vitro studies, thereafter, demonstrated that two
subtype C polymorphisms in 64/65 RT codons accelerate K65R
selection leading to low susceptibility to NRTIs (Brenner et al.,
2006; Invernizzi et al., 2009). The lower genetic barrier of subtype
C, combined with suboptimal treatment regimens in most poor
resource countries, may favor the acquisition of K65R, leading to
limitations in treatment.
In contrast, another report suggested a lower rate of accumu-
lation of drug resistance mutations in subtype C (Soares et al.,
T. Gra¨f, A.R. Pinto / Virology 435 (2013) 170–1781762007). In this study, patient samples from Porto Alegre were
collected and grouped by HIV-1 clade, ARV class, and time
of exposure. The results showed a signiﬁcantly higher frequency
of resistance mutations in subtype B infected patients compared
with subtype C. These ﬁndings were observed for protease
inhibitors (PI) and NRTI, but not for non-NRTI, and were later
supported by Munerato et al. (2010) who found less resistance
mutations to PI and NRTI in subtype C infected patients. Such
observations were somehow unexpected, undermining concerns
that non-subtype B infected individuals are at a disadvantage
because ARV drugs have been designed primarily for subtype B
infections. Reinforcing this point, Scherrer et al. (2011) observed
an improved virological outcome in non-subtype B infected
patients on ARV therapy from the Swiss HIV Cohort Study.
Although subtype C infected patients only accounted for 12% of
the non-B subtype individuals in the Swiss Cohort, these ﬁndings
are consistent with a lower acquisition of drug resistance muta-
tions in subtype C. However, follow-up studies with larger
number of individuals are required to elucidate the real impact
of ARV therapy on non-subtype B strains (Soares et al., 2012).
Naturally occurring mutations and polymorphism that may
impair the effectiveness of entry inhibitors, a new class of ARV
drugs, have also been investigated (Arau´jo et al., 2012; Gonzalez
et al., 2010). These studies indicated that, compared with subtype
B, HIV-1C has a higher number of natural accumulated polymorph-
isms that may cause resistance to entry inhibitors. So far, the Food
and Drug Administration have approved only two entry inhibitors:
Maraviroc, a negative allosteric modulator of the CCR5 cell recep-
tor, and Efuvirtide, which blocks gp41 protein conformational
changes. In Brazil, entry inhibitors are still seldom used except in
cases of multidrug virological failure, even though the genetic
background of HIV-1C may reduce susceptibility to this class of
antiretroviral drug. In vitro and in vivo studies are still required to
conﬁrm such ﬁndings, and careful planning is needed before
employing this class of ARV as rescue therapy.Concluding remarks
The global HIV pandemic is characterized by dynamism and
complexity, and the Brazilian experience with the introduction of
a new variant to a pre-deﬁned epidemic can yield valuable data
regarding HIV expansion and interactions between different
strains. Presently, subtype C is responsible for more than half of
all global HIV infections, mainly in South and East Africa, and
India. Therefore, Southern Brazil represents an important site for
epidemiological studies, where HIV-1C (the most prevalent) and
HIV-1B (the most studied) co-exist in similar frequencies and
infected individuals who have access to antiretroviral treatment
and receive follow-up in a reasonable health care system from an
HIV care stand point. Despite some obscure issues, studies have
shown that HIV-1 subtype C was introduced in Brazil between
1960 and 1980 somewhere in the Southern region, with evidence
pointing to the state of Parana´, and originated from an East
African country. This strain was very successful in spreading
among heterosexual individuals, but not limited to them, becom-
ing highly prevalent in the Brazilian region that is most heavily
affected by AIDS. Whether HIV-1C is the cause of the most
disturbing scenario of AIDS epidemic in Brazil, or whether it just
beneﬁted from the conditions present in the site where it was
introduced, is still up for debate. The recent emergence of subtype C
infections in other Brazilian regions and South American countries
signals the possibility of continental expansion, although it seems
that HIV-1C is not spreading as quickly in these regions as in
Southern Brazil. The understanding of the dynamics and diversity of
the HIV-1 epidemic in Southern Brazil is of utmost importance fordesigning new public health policies, affecting prevention, treat-
ment, and vaccine development. Therefore, continued epidemiologic
surveillance should be maintained in these regions as well as further
evolutionary studies and a close clinical monitoring of infected
patients to ensure a better understanding of dissemination within
a population, differences in virulence, and transmissibility of the
different HIV circulating strains.Acknowledgments
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